You need to be logged in to view this video

Reprogramming the Course of Cancer and Diabetes

Released on Thursday, January 28, 2021•BIOTECH

Share
Facebook Twitter LinkedIn SMS

Genprex's CEO will provide an investor presentation with an overview of the company, its programs in cancer and diabetes, recent milestones, and corporate and clinical updates.

Rodney Varner

Genprex, Inc., CEO and Chairman of the Board

Rodney Varner has served as CEO and chairman of the board for Genprex since August 2012. He has more than thirty-five years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company.